Search Results - robert+schiestl

2 Results Sort By:
Method for Combined Conditioning and Chemoselection in a Single Cycle (UCLA Case No. 2011-478)
SUMMARY: Researchers at UCLA have developed a highly-efficient technique to engraft and select hematopoietic stem cells directly inside a patient. The invention will improve the fidelity of stem cell transplantations and reduce toxic side effects on patients. BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is a mainstay of treatment for...
Published: 2/16/2024   |   Inventor(s): Gay Crooks, Robert Schiestl, Katrin Hacke, Akos Szakmary
Keywords(s): blood cancers, Cancer stem cells, Hematopoietic stem cell transplantation, hematopoietic stem cells, lymphatic cancer, stem cell transplantations, Transplant
Category(s): Therapeutics > Stem Cells And Regenerative Medicine, Therapeutics > Transplant
2009-341 GENOTOXICITY AS A BIOMARKER FOR INFLAMMATION
Genotoxicity As A Biomarker For InflammationSUMMARYResearchers at the UCLA Departments of Pathology and Laboratory Medicine have identified a means to use systemic genotoxicity as a sensitive biomarker for mucosal inflammation, pulmonary inflammation, and their progression to inflammatory bowel disease-associated dysplasia and asthma.BACKGROUNDChronic...
Published: 7/19/2023   |   Inventor(s): Robert Schiestl, Jonathan Braun, Bo Wei, Aya Westbrook
Keywords(s): Diagnostic Markers & Platforms, Inflammatory Diseases
Category(s): Diagnostic Markers, Therapeutics > Inflammation And Inflammatory Diseases